USE OF L-ARGININE IN THE TREATMENT OF EXPERIMENTAL NECROTIZING ENTEROCOLITIS
USE OF L-ARGININE IN THE TREATMENT OF EXPERIMENTAL NECROTIZING ENTEROCOLITIS
复制标题
DOI:
10.1016/0022-3468(95)90567-7
复制
发表时间:
1995-02-01
影响因子:
2.4
通讯作者:
KRANTIS, A
中科院分区:
文献类型:
--
作者:
DILORENZO, M;BASS, J;KRANTIS, A
Although multifactorial in etiology, prematurity and feeding are two of the most common risk factors associated with necrotizing enterocolitis (NEC). To understand the pathogenesis of NEC, the complex interaction between intestinal contents and clearing mechanisms in the immature human gut must be elucidated. Nitric oxide (NO) is a proposed mediator of nonadrenergic noncholinergic neural inhibition, causing relaxation in the gut. In addition to its role as a neuroeffector substance, studies suggest that endogenous formation of NO maintains intestinal mucosal integrity, protecting the gut from blood-borne toxins and tissue-destructive mediators. Thus, NO has a dual role in both gut smooth muscle relaxation and mucosal protection. Because two of the primary risk factors in the development of NEC are prematurity (as it relates to gut dysmotility) and enteral feeding (as it relates to mucosal damage by intraluminal substrate), the authors chose to investigate the role of NO in the pathogenesis of NEC induced by intraluminal injection of acidified casein solution in neonatal piglets. Methods: Having confirmed the consistent induction of NEC both macroscopically and histologically with this model (n = 32), the following were undertaken. Neonatal piglets (